Post-marketing Vaccine Safety Surveillance
Safety and adverse event monitoring don't stop when a vaccine is approved.
Read More
The Challenges of Vaccine Research in Developing Nations
Investigators face several technical, logistical, and cultural challenges when conducting vaccine trials in developing nations.
What Are the R&D and Business Challenges Facing the Vaccine Market?
Although the market is growing, vaccine makers face a variety of technical, research, and business challenges.
Virus-like Particles in Vaccinology: An Overview
Virus-like particles have been used in approved vaccines and several prophylactic and therapeutic vaccine candidates in clinical development.
Behind Every Successful Vaccine Trial Is a Stable Supply Chain
Ensuring the safety of patients in vaccine clinical trials requires close cooperation between sponsors and vaccine suppliers.
Future Trend: Vaccine Technology Transfers to Emerging Markets
As vaccine manufacturers turn their focus to emerging markets, several technical and logistic hurdles remain to be overcome.
A Novel Approach to Managing Patients with Allergic Asthma
Vaccine that incorporates nanoparticles filled with potent stimulators of the innate immune system proves promising in clinical trials.
Personalized Medicines and the Revolution in Vaccine Technology
Clinicians will need new materials and technologies as medicine becomes more personalized.
Seeking a Safer Vaccine against Japanese Encephalitis
A successful government-industry collaboration produced a safer preventive vaccine against this deadly disease.
Purified Protein Vaccines, Recombinant DNA Technology, and H5N1
New vaccine would be the first cell-derived, recombinant protein-based influenza vaccine licensed in the US.
Nasal Influenza Vaccine Shows Promise for Cross-immunity
Early positive clinical trial results for a novel nasal influenza vaccine.
How Should We Manage the H1N1 Post-pandemic Period?
Vaccine expert says that there are many lessons to be learned from the response to the most recent H1N1 pandemic.
Clinical Trials Pave the Way for Single-dose Flu Immunization
Researchers studying influenza vaccines were able to achieve immune response with a single vaccination against H1N1.
BARDA is on the Frontlines of the Global Battle against Flu
How a massive operation of medical countermeasures was mobilized to tackle the ever-present threat of influenza in the US and overseas.
New Nasal Spray Influenza Vaccine May Enable Rapid Pandemic Response
Safe and effective new nasal spray-delivered influenza vaccine could be produced quickly in high quantities during a pandemic infection.
